StockSelector.com
  Research, Select, & Monitor Saturday, May 26, 2018 7:59:39 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Tandem Diabetes Care, Inc.$14.20$.372.68%

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Tandem Diabetes Care, Inc. has an overall rank of 2949 out of 7011 stocks based on 8 positive rankings and 6 negative rankings.

Positive Rankings
90 Day Gain
Tandem Diabetes Care rank is 33
10 Day Gain
Tandem Diabetes Care rank is 49
Historic Revenue Growth
Tandem Diabetes Care rank is 62
Up Ratings Revision
During the past month, the average analyst's rating or recommendation has increased. Among companies that have been upgraded within the past month, Tandem Diabetes Care is ranked 261.
Positive Guidance
Within the past 90 days Tandem Diabetes Care has provided guidance above the consensus estimates. Statistics show companies that provide positive guidance outperform the market in the short-term.
Low Put/Call
Tandem Diabetes Care has a low Put/Call ratio of 0.36 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Tandem Diabetes Care is ranked 757.
Price-to-Sales
Tandem Diabetes Care rank is 1751
Up EPS Surprise
Tandem Diabetes Care beat the consensus earnings estimate when it last reported quarterly earnings.
Negative Rankings
Overbought RSI
The 14 Day Relative-Strength Index for Tandem Diabetes Care is 83.9. An RSI above 70 indicates the stock is overbought. Among companies with a high RSI, Tandem Diabetes Care is ranked 53.
Overbought Stochastics
Tandem Diabetes Care rank is 325
Negative ROA
Tandem Diabetes Care rank is 352
Negative Net Margin
Tandem Diabetes Care rank is 540
High vPut/Call
Tandem Diabetes Care has a high Put/Call ratio of 0.50 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Tandem Diabetes Care is ranked 1372.
Down EPS Surprise
Tandem Diabetes Care missed the consensus earnings estimate when it last reported quarterly earnings.







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.